UK ramipril shortage triggers supply protocol
Ramipril, a blood‑pressure medication used by around six million patients in the United Kingdom, has entered critical shortage. Health officials have placed the drug under a “serious shortage protocol” that limits dispensing to a one‑month supply until 30 October, and pharmacists are barred from substituting alternative treatments without a doctor’s approval.
The shortage, attributed in part to disruptions in the global supply chain linked to the war in the Middle East, follows an April restriction that capped prescriptions of the 1.25 mg strength to 28 tablets. Olivier Picard, chair of the National Pharmacy Association, urged the government to permit pharmacists to make appropriate substitutions, noting that patients receiving fewer tablets will not be charged for the medication.
Entities: Department of Health and Social Care · National Pharmacy Association · Olivier Picard · Ramipril · United Kingdom
Claims
What the coverage asserts, and how well corroborated each claim is across sources.
- [● 3 SOURCES] The shortage is partly caused by disruptions to the global supply chain linked to the war in the Middle East. (All three articles mention the Middle East war as a factor in the shortage.)
- [● 3 SOURCES] Patients who receive fewer ramipril tablets than prescribed will not be charged for the medication. (All three articles note that reduced prescriptions are provided free of charge.)
- [● 3 SOURCES] The Department of Health and Social Care placed ramipril under a serious shortage protocol limiting supply to one month until 30 October. (All three articles mention the protocol and its deadline.)
- [● 3 SOURCES] In April the Department of Health and Social Care restricted 1.25 mg ramipril tablets to a maximum of 28 tablets per prescription. (All three articles refer to the April restriction on the 1.25 mg strength.)
- [● 3 SOURCES] Pharmacists are unable to substitute ramipril without consulting a doctor. (All three articles state that pharmacists cannot prescribe alternatives without GP approval.)
- [● 3 SOURCES] Ramipril is in critical supply in the United Kingdom, affecting about six million patients. (All three articles report the shortage and the number of patients.)
- [● 3 SOURCES] Olivier Picard, chair of the National Pharmacy Association, urged the government to allow pharmacist substitutions for ramipril. (All three articles quote Picard making this request.)